Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Clinical Investigation

• Publication date

  1991-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI115020PMID 1846878PMCID PMC295106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension.

  1989cited by this paper
• Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.

  1989cited by this paper
• Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation.

  1988cited by this paper
• Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.

  1988cited by this paper
• Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.

  1988cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Purification and properties.

  1987cited by this paper
• Cholesteryl ester transfer protein is secreted by Hep G2 cells and contains asparagine-linked carbohydrate and sialic acid.

  1987cited by this paper
• Production and secretion of retinol-binding protein by a human hepatoma cell line, HepG2.

  1987cited by this paper
• Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor.

  1987cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

  1987cited by this paper
• The role of lipoproteins in the degradation of platelet-activating factor.

  1986cited by this paper
• Synthesis and secretion of lecithin-cholesterol acyltransferase by the human hepatoma cell line HepG2.

  1986cited by this paper
• Antigenic relatedness between human lecithin-cholesterol acyltransferase and phospholipases of the A2 family.

  1986cited by this paper
• Platelet activating factor: a biologically active phosphoglyceride.

  1986cited by this paper
• The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).

  1985cited by this paper
• Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.

  1985cited by this paper
• Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids

  1985cited by this paper
• Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

  1984cited by this paper
• Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.

  1983cited by this paper
• Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line.

  1982cited by this paper
• Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity.

  1982cited by this paper
• Characterization of the major apolipoproteins secreted by two human hepatoma cell lines.

  1981cited by this paper
• A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

  1981cited by this paper
• [25] Assay for lecithin: Cholesterol acyltransferase

  1981cited by this paper
• Assay for lecithin: cholesterol acyltransferase.

  1981cited by this paper
• Characterization of the asialoglycoprotein receptor in a continuous hepatoma line.

  1981cited by this paper
• Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture.

  1981cited by this paper
• Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.

  1980cited by this paper
• High-performance aqueous gel permeation chromatography of human serum lipoproteins.

  1980cited by this paper
• Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF).

  1980cited by this paper
• Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

  1980cited by this paper
• Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

  1979cited by this paper
• Measurement of growth and viability of cells in culture.

  1979cited by this paper
• Hepatotoxicity of salicylates in monolayer cell cultures.

  1978cited by this paper
• Conjugation of antibodies with fluorochromes: modifications to the standard methods.

  1976cited by this paper
• Histidine at the active site of phospholipase A2.

  1974cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• PAFAH1B3 regulates Papillary thyroid carcinoma cell proliferation and metastasis by affecting the EMT.

  2023cites this paper
• Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2.

  2022cites this paper
• Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma

  2021cites this paper
• PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration

  2021cites this paper
• Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma

  2019cites this paper
• PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.

  2018cites this paper
• Evaluating inhibitory potential targeting cholesteryl ester transfer protein (CETP) by hydroxycitric acid (HCA) found in Garcinia species through kinetic and in-silico technique

  2016influential citation
• Detection and Characterization of Phospholipase A2 (PLA2) in Caiman latirostris and Caiman yacare Plasma

  2013cites this paper
• Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases Modulation of oxidative stress, infl ammation, and atherosclerosis by lipoprotein-associated phospholipase A 2

  2012cites this paper
• Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

  2012cites this paper
• In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism

  2011cites this paper
• Characterization of Serum Phospholipase A2 Activity in Three Diverse Species of West African Crocodiles

  2011cites this paper
• Investigation of the function of lipoprotein-associated phospholipase A₂ in lipid metabolism

  2009cites this paper
• Alterations of Paraoxonase and Platelet-Activating Factor Acetylhydrolase Activities in Patients on Peritoneal Dialysis

  2004cites this paper
• Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells

  2003cites this paper
• Plasma platelet activating factor-acetylhydrolase (PAF-AH).

  2003cites this paper
• Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways*

  2002cites this paper
• Receptor-dependent Metabolism of Platelet-activating Factor in Murine Macrophages*

  2002cites this paper
• Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

  2002cites this paper
• Platelet-activating factor acetylhydrolase.

  2002cites this paper
• Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.

  2002cites this paper
• N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL.

  2001cites this paper
• The Expression and Localization of Plasma Platelet-activating Factor Acetylhydrolase in Endotoxemic Rats*

  2000cites this paper
• Platelet-activating factor acetylhydrolases in health and disease.

  2000cites this paper
• Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.

  2000cites this paper
• Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation

  2000cites this paper
• Platelet-Activating Factor

  2000cites this paper
• Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.

  1999cites this paper
• Inhibitory effect of interleukin-8 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages.

  1999cites this paper
• Inhibitory Effect of Interleukin-8 on the Secretion of Platelet-Activating Factor Acetylhydrolase by Human Decidual Macrophages

  1999cites this paper
• Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

  1999cites this paper
• Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.

  1999cites this paper
• Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma.

  1999cites this paper
• In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response.

  1999cites this paper
• In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response.

  1999cites this paper
• Roles of plasma platelet-activating factor acetylhydrolase in allergic, inflammatory, and atherosclerotic diseases.

  1998cites this paper
• Expression of Plasma Platelet-activating Factor Acetylhydrolase Is Transcriptionally Regulated by Mediators of Inflammation*

  1998cites this paper
• A Mutation in Plasma Platelet-activating Factor Acetylhydrolase (Val279Phe) Is a Genetic Risk Factor for Cerebral Hemorrhage but not for Hypertension

  1998cites this paper
• Secretion of platelet-activating factor acetylhydrolase by human decidual macrophages.

  1998cites this paper
• Platelet‐activating factor acetylhydrolase in seminal plasma: A brief review

  1998cites this paper
• Platelet-activating Factor Acetylhydrolases*

  1997cites this paper
• Cell-specific Regulation of Expression of Plasma-type Platelet-activating Factor Acetylhydrolase in the Liver*

  1997cites this paper
• A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.

  1997cites this paper
• REDUCED PAF‐ACETYLHYDROLASE ACTIVITY IS ASSOCIATED WITH POSTINJURY MULTIPLE ORGAN FAILURE

  1997cites this paper
• Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.

  1997cites this paper
• Platelet-Activating Factor (PAF) Up-Regulates Plasma and Tissue PAF-Acetylhydrolase Activity in the Rat: Effect of Cycloheximide

  1997cites this paper
• Platelet-activating factor in human decidua: its role in parturition and preterm labor

  1997cites this paper
• Effects of protein kinase C activation and inhibition on endothelin-1 release from human aortic and pulmonary artery endothelial cells: comparison with effects on bovine endothelin-1 and human prostaglandin I2 release.

  1997cites this paper
• Lipid Second Messengers

  1996cites this paper
• Direct interactions of plasminogen activators with human aortic and pulmonary artery endothelial cells in vitro: implications for thrombolytic therapy.

  1996cites this paper
• Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.

  1996cites this paper
• Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.

  1996cites this paper
• Platelet-Activating Factor and PAF-Like Mimetics

  1996cites this paper
• Mammalian platelet-activating factor acetylhydrolases.

  1996cites this paper
• Changes in glycerophospholipid profile in experimental nephrotic syndrome.

  1996cites this paper
• The fate of platelet-activating factor: PAF acetylhydrolases from plasma and tissues

  1996cites this paper
• Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.

  1996cites this paper
• Deficiency of plasma platelet‐activating factor acetylhydrolase: Roles of blood cells

  1996cites this paper
• Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role.

  1995cites this paper
• Stimulation of platelet-activating factor synthesis in polymorphonuclear leukocytes from streptozotocin-induced diabetic rats.

  1995cites this paper
• Platelet-activating factor: the biosynthetic and catabolic enzymes.

  1995cites this paper
• Platelet-activating factor acetylhydrolases in Caco-2 cells and epithelium of normal and ulcerative colitis patients.

  1995cites this paper
• Platelet‐activating factor: a mediator for clinicians

  1995cites this paper
• Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.

  1995cites this paper
• Metabolic processing of PAF

  1995cites this paper
• Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

  1995cites this paper
• Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.

  1994cites this paper
• Differentiation induced increase of platelet-activating factor acetylhydrolase in HL-60 cells.

  1994cites this paper
• High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.

  1994cites this paper
• The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.

  1994cites this paper
• Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.

  1994cites this paper
• PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis.

  1994cites this paper
• Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis.

  1994cites this paper
• Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes.

  1994cites this paper
• 7 – Cellular Sources of Platelet-Activating Factor and Related Lipids

  1994cites this paper
• 9 – Platelet-Activating Factor: Receptors and Receptor Antagonists

  1994cites this paper
• Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes

  1994cites this paper
• Platelet-activating factor antagonists: scientific background and possible clinical applications.

  1994cites this paper
• Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages.

  1993cites this paper
• Platelet-activating factor: a phospholipid autacoid with diverse actions.

  1993cites this paper
• Effect of 17 beta-estradiol on secretion of platelet-activating factor acetylhydrolase by HepG2 cells.

  1993cites this paper
• Secretion of platelet-activating factor acetylhydrolase following phorbol ester-stimulated differentiation of HL-60 cells.

  1993cites this paper
• Platelet-Activating Factor: Its Regulation in Parturition

  1993cites this paper
• Human platelets release a paf-acether: Acetylhydrolase similar to that in plasma

  1993cites this paper
• Hormonal regulation of platelet-activating factor-acetyltransferase activity in rat tissues.

  1993cites this paper
• Platelet‐Activating Factor Acetylhydrolase in Plasma Lipoproteins From Patients With Ischemic Stroke

  1992cites this paper
• Membrane-Derived Lipid Second Messengers as Targets for Neuroprotection: Platelet-Activating Factor

  1992cites this paper
• An investigation of platelet-activating factor metabolism during normal and pre-eclamptic pregnancies.

  1992influential citation
• Platelet‐activating factor acetylhydrolase activity in red blood cell‐stroma from patients with cerebral thrombosis

  1992cites this paper
• PAF acetylhydrolase activities in human systemic lupus erythematosus and lupus-prone mice.

  1992cites this paper
• Increased levels of blood platelet‐activating factor (PAF) and PAF‐like lipids in patients with ischemic stroke

  1992cites this paper
• Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.

  1992cites this paper
• Platelet-activating factor and its metabolic effects.

  1991cites this paper
• Serum PAF acetylhydrolase and chronic cholestasis.

  1991cites this paper
• Platelet-activating factor acetylhydrolase in plasma lipoproteins of healthy men and women.

  1991cites this paper
• Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.

  1991cites this paper